Motif ID: Klf1
Z-value: 2.866
Transcription factors associated with Klf1:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Klf1 | ENSMUSG00000054191.7 | Klf1 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Klf1 | mm10_v2_chr8_+_84901928_84901992 | -0.50 | 2.8e-06 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.0 | 81.4 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
8.9 | 26.8 | GO:0099548 | trans-synaptic signaling by nitric oxide(GO:0099548) |
7.7 | 23.0 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
6.8 | 6.8 | GO:1905072 | cardiac jelly development(GO:1905072) |
6.2 | 24.7 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
5.9 | 53.5 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
5.7 | 22.8 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
5.6 | 27.8 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
5.5 | 21.9 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
5.1 | 15.3 | GO:1990523 | bone regeneration(GO:1990523) |
4.9 | 14.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
4.7 | 23.7 | GO:1902287 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
4.5 | 45.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
4.2 | 16.8 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
4.0 | 12.1 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
4.0 | 12.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
3.8 | 22.9 | GO:0009405 | pathogenesis(GO:0009405) |
3.8 | 3.8 | GO:0071895 | odontoblast differentiation(GO:0071895) |
3.7 | 11.0 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
3.6 | 3.6 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
3.6 | 14.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
3.5 | 14.2 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
3.5 | 38.7 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
3.5 | 10.6 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
3.5 | 28.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
3.4 | 13.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
3.3 | 10.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
3.3 | 32.6 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
3.3 | 16.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
3.2 | 16.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
3.2 | 19.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
3.1 | 15.6 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
3.1 | 21.7 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
3.1 | 9.3 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
3.1 | 9.2 | GO:0061075 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
3.0 | 30.1 | GO:0046959 | habituation(GO:0046959) |
3.0 | 8.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
2.9 | 17.1 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
2.8 | 5.6 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
2.8 | 14.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
2.8 | 8.3 | GO:1903011 | negative regulation of bone development(GO:1903011) |
2.7 | 8.0 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
2.7 | 8.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
2.6 | 15.7 | GO:0019695 | choline metabolic process(GO:0019695) |
2.6 | 36.3 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
2.6 | 7.7 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
2.6 | 7.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
2.5 | 7.6 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
2.5 | 7.6 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
2.5 | 20.2 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
2.5 | 7.5 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
2.5 | 7.4 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
2.4 | 14.5 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
2.4 | 2.4 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
2.4 | 9.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
2.3 | 18.7 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
2.3 | 6.9 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
2.3 | 16.1 | GO:0031424 | keratinization(GO:0031424) |
2.3 | 6.9 | GO:0001803 | antibody-dependent cellular cytotoxicity(GO:0001788) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
2.3 | 6.8 | GO:0046098 | guanine metabolic process(GO:0046098) |
2.3 | 9.1 | GO:0061526 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
2.3 | 11.3 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
2.2 | 13.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
2.2 | 8.8 | GO:0035793 | cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
2.2 | 6.5 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
2.2 | 15.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
2.1 | 6.4 | GO:0019043 | establishment of viral latency(GO:0019043) |
2.1 | 6.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
2.1 | 24.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
2.1 | 6.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
2.0 | 6.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
2.0 | 8.0 | GO:0051866 | general adaptation syndrome(GO:0051866) |
2.0 | 6.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
2.0 | 13.9 | GO:0071280 | cellular response to copper ion(GO:0071280) |
2.0 | 5.9 | GO:0072720 | cellular response to UV-A(GO:0071492) response to dithiothreitol(GO:0072720) |
1.9 | 9.7 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
1.9 | 11.6 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
1.9 | 5.8 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
1.9 | 3.8 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
1.9 | 11.4 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
1.9 | 1.9 | GO:0071317 | cellular response to isoquinoline alkaloid(GO:0071317) |
1.9 | 9.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.9 | 9.3 | GO:0008355 | olfactory learning(GO:0008355) |
1.9 | 11.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
1.8 | 7.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.8 | 5.4 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
1.8 | 19.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
1.8 | 14.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.8 | 7.1 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
1.8 | 5.3 | GO:0030070 | insulin processing(GO:0030070) |
1.8 | 7.0 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
1.7 | 12.1 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
1.7 | 6.8 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
1.7 | 5.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.7 | 11.9 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.7 | 11.8 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
1.7 | 6.7 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
1.7 | 10.0 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
1.6 | 1.6 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.6 | 14.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.6 | 11.4 | GO:0061312 | BMP signaling pathway involved in heart development(GO:0061312) |
1.6 | 24.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.6 | 14.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.6 | 9.4 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
1.6 | 7.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.6 | 10.9 | GO:0033227 | dsRNA transport(GO:0033227) |
1.5 | 6.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.5 | 18.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.5 | 7.7 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
1.5 | 4.6 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
1.5 | 10.6 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
1.5 | 7.4 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
1.5 | 4.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.5 | 14.8 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
1.5 | 1.5 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
1.4 | 5.8 | GO:0036258 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
1.4 | 11.5 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
1.4 | 21.3 | GO:0043482 | pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) |
1.4 | 12.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.4 | 5.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
1.4 | 5.6 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
1.4 | 5.6 | GO:0015888 | thiamine transport(GO:0015888) |
1.4 | 10.9 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
1.4 | 4.1 | GO:0035617 | stress granule disassembly(GO:0035617) |
1.4 | 4.1 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
1.4 | 5.4 | GO:0048069 | eye pigmentation(GO:0048069) |
1.4 | 5.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.3 | 5.4 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
1.3 | 4.0 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
1.3 | 5.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.3 | 8.0 | GO:0006108 | malate metabolic process(GO:0006108) |
1.3 | 2.6 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.3 | 4.0 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.3 | 4.0 | GO:0043379 | rRNA export from nucleus(GO:0006407) memory T cell differentiation(GO:0043379) |
1.3 | 22.4 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.3 | 3.9 | GO:0061744 | motor behavior(GO:0061744) |
1.3 | 6.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.3 | 14.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
1.3 | 2.6 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
1.3 | 7.8 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
1.3 | 2.6 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
1.3 | 3.8 | GO:0002159 | desmosome assembly(GO:0002159) |
1.3 | 6.3 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
1.3 | 6.3 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
1.2 | 3.7 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
1.2 | 2.5 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
1.2 | 27.3 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
1.2 | 3.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.2 | 3.7 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
1.2 | 21.9 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
1.2 | 21.8 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
1.2 | 9.6 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
1.2 | 4.8 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
1.2 | 23.8 | GO:0046599 | regulation of centriole replication(GO:0046599) |
1.2 | 11.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.2 | 5.9 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.2 | 4.7 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
1.2 | 1.2 | GO:0002086 | diaphragm contraction(GO:0002086) |
1.2 | 4.6 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
1.2 | 8.1 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
1.1 | 10.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.1 | 1.1 | GO:0072197 | renal vesicle induction(GO:0072034) ureter morphogenesis(GO:0072197) |
1.1 | 5.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
1.1 | 4.5 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
1.1 | 7.9 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.1 | 6.8 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
1.1 | 4.5 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.1 | 10.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.1 | 7.8 | GO:0036376 | sodium ion export from cell(GO:0036376) |
1.1 | 3.3 | GO:0098886 | modification of dendritic spine(GO:0098886) |
1.1 | 3.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.1 | 3.3 | GO:1900365 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) positive regulation of mRNA polyadenylation(GO:1900365) |
1.1 | 1.1 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
1.1 | 2.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.1 | 8.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
1.1 | 5.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.1 | 2.2 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
1.1 | 18.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
1.1 | 3.2 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
1.1 | 4.3 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
1.1 | 1.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.1 | 7.5 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
1.1 | 7.4 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
1.1 | 6.3 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
1.1 | 9.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
1.0 | 4.2 | GO:0040010 | B-1 B cell homeostasis(GO:0001922) positive regulation of growth rate(GO:0040010) |
1.0 | 4.2 | GO:0009597 | detection of virus(GO:0009597) |
1.0 | 2.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.0 | 4.1 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
1.0 | 3.0 | GO:2000812 | response to rapamycin(GO:1901355) regulation of barbed-end actin filament capping(GO:2000812) |
1.0 | 3.0 | GO:0015844 | monoamine transport(GO:0015844) |
1.0 | 4.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.0 | 4.0 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
1.0 | 16.9 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.0 | 2.0 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
1.0 | 7.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.0 | 9.8 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
1.0 | 1.9 | GO:0034759 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
1.0 | 8.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.0 | 12.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
1.0 | 2.9 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.9 | 3.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.9 | 22.4 | GO:0071625 | vocalization behavior(GO:0071625) |
0.9 | 26.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.9 | 2.8 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.9 | 6.5 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.9 | 8.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.9 | 1.8 | GO:0021759 | globus pallidus development(GO:0021759) |
0.9 | 2.8 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
0.9 | 0.9 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.9 | 10.9 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.9 | 7.2 | GO:0048265 | response to pain(GO:0048265) |
0.9 | 9.8 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.9 | 10.6 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.9 | 5.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.9 | 27.2 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.9 | 8.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.9 | 2.6 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.9 | 6.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.9 | 4.3 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.8 | 25.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.8 | 5.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.8 | 6.7 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.8 | 11.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.8 | 5.0 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.8 | 2.5 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) |
0.8 | 5.8 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.8 | 4.1 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.8 | 2.5 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.8 | 2.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.8 | 6.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.8 | 1.6 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.8 | 9.7 | GO:0016322 | neuron remodeling(GO:0016322) |
0.8 | 4.0 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.8 | 1.6 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.8 | 32.9 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.8 | 3.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.8 | 10.4 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.8 | 4.8 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.8 | 3.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.8 | 0.8 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.8 | 3.2 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.8 | 18.0 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.8 | 2.3 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.8 | 3.1 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.8 | 2.3 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.8 | 2.3 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.8 | 3.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.8 | 2.3 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.8 | 2.3 | GO:1901911 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.8 | 1.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.8 | 4.5 | GO:0043585 | nose morphogenesis(GO:0043585) |
0.8 | 2.3 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.7 | 0.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.7 | 12.0 | GO:0070986 | left/right axis specification(GO:0070986) |
0.7 | 4.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.7 | 3.7 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.7 | 3.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.7 | 2.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.7 | 5.9 | GO:0014850 | response to muscle activity(GO:0014850) |
0.7 | 5.1 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.7 | 4.3 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.7 | 20.9 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.7 | 5.0 | GO:0034766 | negative regulation of ion transmembrane transport(GO:0034766) |
0.7 | 2.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.7 | 2.1 | GO:0016240 | autophagosome docking(GO:0016240) |
0.7 | 2.8 | GO:0032456 | endocytic recycling(GO:0032456) |
0.7 | 2.1 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.7 | 6.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.7 | 48.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.7 | 0.7 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.7 | 1.4 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.7 | 3.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.7 | 2.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.7 | 2.8 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.7 | 6.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.7 | 2.0 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.7 | 25.7 | GO:0015914 | phospholipid transport(GO:0015914) |
0.7 | 1.3 | GO:0010248 | B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.7 | 4.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.7 | 7.3 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.7 | 4.7 | GO:0015879 | carnitine transport(GO:0015879) |
0.7 | 4.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.7 | 3.3 | GO:0099550 | trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
0.7 | 5.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.7 | 18.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.7 | 2.0 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.7 | 15.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.7 | 0.7 | GO:0001975 | response to amphetamine(GO:0001975) response to amine(GO:0014075) |
0.7 | 5.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 1.9 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.6 | 3.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.6 | 4.5 | GO:0015862 | uridine transport(GO:0015862) |
0.6 | 1.9 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.6 | 5.1 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.6 | 7.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.6 | 0.6 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.6 | 1.9 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.6 | 1.9 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.6 | 11.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.6 | 18.0 | GO:0034605 | cellular response to heat(GO:0034605) |
0.6 | 9.9 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.6 | 3.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.6 | 14.8 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.6 | 4.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.6 | 4.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.6 | 1.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.6 | 1.8 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.6 | 6.0 | GO:0042168 | heme metabolic process(GO:0042168) |
0.6 | 2.4 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.6 | 1.8 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.6 | 16.0 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.6 | 5.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.6 | 3.5 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.6 | 2.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.6 | 3.5 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.6 | 9.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.6 | 4.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.6 | 2.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.6 | 2.3 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.6 | 16.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.6 | 3.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.6 | 4.0 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.6 | 6.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.6 | 7.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.6 | 6.8 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.6 | 8.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.6 | 3.4 | GO:0048254 | snoRNA localization(GO:0048254) |
0.6 | 2.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.6 | 1.7 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
0.5 | 1.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 9.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.5 | 7.0 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.5 | 10.3 | GO:0022038 | corpus callosum development(GO:0022038) |
0.5 | 3.2 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.5 | 4.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.5 | 8.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.5 | 6.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.5 | 6.3 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.5 | 3.7 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.5 | 2.1 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) |
0.5 | 3.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.5 | 8.8 | GO:0000338 | protein deneddylation(GO:0000338) |
0.5 | 0.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.5 | 0.5 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.5 | 2.1 | GO:0051309 | female meiosis chromosome separation(GO:0051309) |
0.5 | 2.5 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.5 | 2.0 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.5 | 1.5 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.5 | 3.0 | GO:0034214 | protein hexamerization(GO:0034214) |
0.5 | 58.7 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.5 | 2.9 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) inosine biosynthetic process(GO:0046103) |
0.5 | 0.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.5 | 2.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.5 | 14.0 | GO:1902305 | regulation of sodium ion transmembrane transport(GO:1902305) |
0.5 | 2.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.5 | 6.7 | GO:0005980 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.5 | 2.9 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.5 | 13.1 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.5 | 4.7 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.5 | 2.8 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.5 | 28.5 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.5 | 4.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.5 | 8.2 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.5 | 4.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.5 | 2.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.4 | 1.8 | GO:0015825 | L-serine transport(GO:0015825) |
0.4 | 2.2 | GO:0051100 | negative regulation of binding(GO:0051100) |
0.4 | 4.9 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.4 | 8.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 3.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.4 | 2.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.4 | 3.5 | GO:0031639 | plasminogen activation(GO:0031639) |
0.4 | 1.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 1.7 | GO:0086011 | membrane repolarization during action potential(GO:0086011) regulation of membrane repolarization during action potential(GO:0098903) |
0.4 | 1.3 | GO:0010896 | negative regulation of sequestering of triglyceride(GO:0010891) regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.4 | 1.3 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.4 | 3.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 3.9 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.4 | 0.4 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.4 | 3.4 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.4 | 1.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.4 | 9.7 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.4 | 3.0 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.4 | 2.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.4 | 1.3 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.4 | 4.5 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.4 | 1.2 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.4 | 1.6 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.4 | 9.8 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.4 | 6.0 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.4 | 0.8 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.4 | 6.8 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.4 | 2.8 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.4 | 2.0 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.4 | 0.8 | GO:0070570 | regulation of neuron projection regeneration(GO:0070570) |
0.4 | 1.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.4 | 0.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.4 | 0.7 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.4 | 4.0 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.4 | 1.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.4 | 1.8 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
0.4 | 1.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.3 | 1.0 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.3 | 3.8 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.3 | 1.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.3 | 2.4 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.3 | 2.7 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.3 | 2.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 0.7 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 1.0 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.3 | 1.3 | GO:0015871 | choline transport(GO:0015871) negative regulation of RIG-I signaling pathway(GO:0039536) |
0.3 | 2.0 | GO:0098707 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.3 | 0.7 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 4.8 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.3 | 1.0 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.3 | 5.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.3 | 2.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 3.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.3 | 4.8 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.3 | 2.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 4.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.3 | 0.9 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.3 | 0.9 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.3 | 0.9 | GO:0021837 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) positive regulation of mitotic cell cycle DNA replication(GO:1903465) |
0.3 | 1.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.3 | 4.6 | GO:0034389 | lipid particle organization(GO:0034389) |
0.3 | 5.7 | GO:0097320 | membrane tubulation(GO:0097320) |
0.3 | 2.4 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.3 | 1.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 1.8 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.3 | 0.9 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.3 | 1.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.3 | 1.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 1.7 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.3 | 2.6 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.3 | 2.0 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.3 | 0.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.3 | 1.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.3 | 3.9 | GO:0048278 | vesicle docking(GO:0048278) |
0.3 | 1.6 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 0.8 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) |
0.3 | 1.1 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.3 | 0.8 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.3 | 0.5 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.3 | 2.2 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.3 | 1.1 | GO:0007343 | egg activation(GO:0007343) |
0.3 | 3.5 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.3 | 6.7 | GO:0007032 | endosome organization(GO:0007032) |
0.3 | 4.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 1.3 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 2.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.3 | 1.8 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.3 | 5.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.3 | 0.8 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.3 | 2.3 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.3 | 1.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.3 | 2.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 1.7 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.2 | 0.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 4.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 7.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 2.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 1.9 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.2 | 4.2 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 5.1 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.2 | 3.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 2.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 6.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 0.4 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.2 | 0.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 1.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.2 | 2.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 1.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 2.9 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.2 | 0.6 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.2 | 0.8 | GO:1903028 | asymmetric Golgi ribbon formation(GO:0090164) regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.2 | 1.7 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.2 | 0.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 1.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 2.7 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 0.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 3.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.2 | 0.8 | GO:0015786 | UDP-glucose transport(GO:0015786) |
0.2 | 0.8 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 1.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 4.8 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.2 | 3.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 6.0 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 3.3 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.2 | 1.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 1.1 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.2 | 0.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 2.9 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 8.6 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.2 | 0.5 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.2 | 0.7 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.2 | 3.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 1.0 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.2 | 0.5 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.2 | 0.7 | GO:1990034 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
0.2 | 1.4 | GO:0010829 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.2 | 0.7 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.2 | 3.2 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.2 | 1.2 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.2 | 0.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.5 | GO:0090399 | replicative senescence(GO:0090399) |
0.2 | 2.3 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.2 | 21.6 | GO:0050890 | cognition(GO:0050890) |
0.2 | 0.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 1.6 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.2 | 6.5 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.2 | 1.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 1.3 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.2 | 0.6 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 1.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 0.9 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.2 | 1.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 2.1 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 3.6 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.4 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.1 | 1.3 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 1.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.7 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 1.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 2.0 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
0.1 | 0.1 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.1 | GO:0007521 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) muscle cell fate determination(GO:0007521) |
0.1 | 6.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.4 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.1 | 1.2 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 0.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.8 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
0.1 | 0.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.9 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.1 | 1.4 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 2.0 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 1.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.6 | GO:0032782 | bile acid secretion(GO:0032782) positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 1.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 1.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.5 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 3.2 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 1.9 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.5 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.8 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.1 | 2.1 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.6 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.2 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 1.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 11.5 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 2.6 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 4.2 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.1 | 1.8 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.1 | 1.1 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 5.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 2.3 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 1.1 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 1.1 | GO:0042407 | mitochondrial protein processing(GO:0034982) cristae formation(GO:0042407) |
0.1 | 0.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 1.1 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.1 | 2.9 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.9 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 1.0 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 1.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 2.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 1.5 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.1 | 0.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 1.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 2.6 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.1 | 0.1 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.5 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.8 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 1.5 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.1 | 4.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 4.1 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.4 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 1.2 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.3 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 1.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 1.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 2.7 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.8 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.6 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 4.9 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 2.3 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 1.6 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.1 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 1.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 6.0 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.6 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.2 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.8 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.0 | 0.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.3 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.0 | 0.9 | GO:0000045 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.0 | 0.1 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.2 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.0 | 0.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 1.6 | GO:0042073 | intraciliary transport(GO:0042073) |
0.0 | 0.3 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 0.6 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.0 | 0.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 1.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.5 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.0 | 0.3 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.0 | 0.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.3 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 1.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.9 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.2 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.5 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.1 | 64.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
13.2 | 39.7 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
10.9 | 32.8 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
8.0 | 80.3 | GO:0045298 | tubulin complex(GO:0045298) |
6.0 | 6.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
5.9 | 23.5 | GO:0032280 | symmetric synapse(GO:0032280) |
5.8 | 23.0 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
5.1 | 5.1 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
4.8 | 14.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
4.2 | 16.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
4.0 | 16.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
3.7 | 11.2 | GO:0044299 | C-fiber(GO:0044299) |
3.6 | 10.8 | GO:0044194 | cytolytic granule(GO:0044194) |
3.5 | 24.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
3.4 | 37.2 | GO:0032426 | stereocilium tip(GO:0032426) |
3.1 | 18.8 | GO:0008091 | spectrin(GO:0008091) |
2.7 | 5.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
2.6 | 7.8 | GO:0045160 | myosin I complex(GO:0045160) |
2.4 | 41.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
2.3 | 11.5 | GO:0001533 | cornified envelope(GO:0001533) |
2.3 | 6.8 | GO:0043512 | inhibin-betaglycan-ActRII complex(GO:0034673) inhibin A complex(GO:0043512) |
2.2 | 19.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
2.1 | 23.4 | GO:0032584 | growth cone membrane(GO:0032584) |
2.1 | 8.4 | GO:1990769 | proximal neuron projection(GO:1990769) |
2.1 | 18.8 | GO:0043235 | receptor complex(GO:0043235) |
2.1 | 2.1 | GO:0019034 | viral replication complex(GO:0019034) |
2.0 | 2.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.9 | 30.9 | GO:0005614 | interstitial matrix(GO:0005614) |
1.8 | 23.7 | GO:0044327 | dendritic spine head(GO:0044327) |
1.8 | 36.0 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
1.8 | 17.9 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.8 | 5.3 | GO:0048179 | activin receptor complex(GO:0048179) |
1.7 | 17.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.7 | 33.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.7 | 26.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
1.7 | 3.3 | GO:0097444 | spine apparatus(GO:0097444) |
1.6 | 4.9 | GO:0005940 | septin ring(GO:0005940) |
1.6 | 40.4 | GO:0071565 | nBAF complex(GO:0071565) |
1.6 | 27.0 | GO:0000124 | SAGA complex(GO:0000124) |
1.5 | 19.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.5 | 2.9 | GO:0031527 | filopodium membrane(GO:0031527) |
1.4 | 4.3 | GO:0000802 | transverse filament(GO:0000802) |
1.4 | 22.4 | GO:0000145 | exocyst(GO:0000145) |
1.4 | 8.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.4 | 13.8 | GO:0097060 | synaptic membrane(GO:0097060) |
1.4 | 24.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
1.4 | 65.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.3 | 9.3 | GO:0070695 | FHF complex(GO:0070695) |
1.3 | 4.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.3 | 3.9 | GO:0016342 | catenin complex(GO:0016342) |
1.3 | 2.5 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
1.3 | 6.3 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
1.3 | 36.4 | GO:0032590 | dendrite membrane(GO:0032590) |
1.2 | 32.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.2 | 14.2 | GO:0030057 | desmosome(GO:0030057) |
1.2 | 18.9 | GO:0043196 | varicosity(GO:0043196) |
1.2 | 4.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.1 | 4.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
1.1 | 12.2 | GO:0005642 | annulate lamellae(GO:0005642) |
1.1 | 13.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.1 | 17.6 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
1.1 | 89.7 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
1.1 | 5.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.1 | 2.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.0 | 11.3 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
1.0 | 3.9 | GO:0016011 | dystroglycan complex(GO:0016011) |
1.0 | 8.7 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
1.0 | 3.8 | GO:0031084 | BLOC-2 complex(GO:0031084) |
1.0 | 15.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.9 | 4.7 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.9 | 3.7 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.9 | 5.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.9 | 65.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.9 | 4.5 | GO:1902710 | GABA receptor complex(GO:1902710) |
0.9 | 5.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.8 | 42.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.8 | 7.6 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.8 | 7.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.8 | 4.2 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.8 | 14.8 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.8 | 10.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.8 | 5.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.8 | 3.8 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.7 | 17.9 | GO:0005921 | gap junction(GO:0005921) |
0.7 | 2.2 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
0.7 | 8.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.7 | 2.9 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.7 | 29.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.7 | 2.8 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.7 | 5.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.7 | 2.8 | GO:0005745 | m-AAA complex(GO:0005745) |
0.7 | 6.9 | GO:0071439 | clathrin complex(GO:0071439) |
0.7 | 33.5 | GO:0016235 | aggresome(GO:0016235) |
0.7 | 12.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.7 | 5.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.7 | 4.7 | GO:0005883 | neurofilament(GO:0005883) |
0.7 | 25.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.7 | 2.0 | GO:0014802 | terminal cisterna(GO:0014802) |
0.7 | 25.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.7 | 2.0 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
0.6 | 3.2 | GO:0042581 | specific granule(GO:0042581) |
0.6 | 3.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.6 | 9.5 | GO:0002102 | podosome(GO:0002102) |
0.6 | 11.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.6 | 1.9 | GO:0060091 | kinocilium(GO:0060091) |
0.6 | 7.9 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.6 | 2.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.6 | 13.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.6 | 14.5 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.6 | 3.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.6 | 3.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.6 | 2.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.6 | 5.8 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.6 | 3.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.6 | 3.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.6 | 21.1 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.6 | 2.8 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.5 | 1.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.5 | 1.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 3.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.5 | 7.4 | GO:0034704 | calcium channel complex(GO:0034704) |
0.5 | 5.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.5 | 2.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 3.1 | GO:0035976 | AP1 complex(GO:0035976) |
0.5 | 13.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.5 | 9.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.5 | 7.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.5 | 2.0 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.5 | 1.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.5 | 4.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.5 | 8.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.5 | 55.9 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.5 | 39.7 | GO:0043204 | perikaryon(GO:0043204) |
0.5 | 8.7 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.5 | 2.3 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.5 | 1.8 | GO:0071942 | XPC complex(GO:0071942) |
0.5 | 0.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 1.3 | GO:0045179 | apical cortex(GO:0045179) |
0.4 | 1.7 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.4 | 3.5 | GO:0045180 | basal cortex(GO:0045180) |
0.4 | 28.4 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 15.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.4 | 94.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 9.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.4 | 28.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.4 | 1.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.4 | 2.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 4.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 2.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 10.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.4 | 2.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 6.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.4 | 22.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.4 | 59.5 | GO:0099572 | postsynaptic specialization(GO:0099572) |
0.4 | 9.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.4 | 5.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.4 | 0.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) omegasome membrane(GO:1903349) |
0.4 | 23.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 12.2 | GO:0014704 | intercalated disc(GO:0014704) |
0.4 | 4.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 1.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.3 | 2.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.3 | 2.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 2.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 7.5 | GO:0001741 | XY body(GO:0001741) |
0.3 | 2.3 | GO:0098845 | postsynaptic recycling endosome(GO:0098837) postsynaptic endosome(GO:0098845) |
0.3 | 3.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 2.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 2.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.3 | 7.7 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.3 | 3.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 66.0 | GO:0000139 | Golgi membrane(GO:0000139) |
0.3 | 2.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 1.2 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.3 | 0.9 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.3 | 16.8 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 5.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.3 | 0.8 | GO:0030133 | transport vesicle(GO:0030133) |
0.3 | 3.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 2.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 2.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 1.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 2.8 | GO:0005902 | microvillus(GO:0005902) |
0.3 | 1.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 1.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 3.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 17.4 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.2 | 28.4 | GO:0005770 | late endosome(GO:0005770) |
0.2 | 1.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 2.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 1.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 4.1 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 1.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 3.0 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 22.2 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 10.3 | GO:0072686 | mitotic spindle(GO:0072686) |
0.2 | 3.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 4.8 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.2 | 3.8 | GO:0042383 | sarcolemma(GO:0042383) |
0.2 | 0.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 17.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 1.6 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 2.1 | GO:0005903 | brush border(GO:0005903) |
0.2 | 3.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 1.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 1.0 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 5.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 0.5 | GO:0034657 | GID complex(GO:0034657) |
0.2 | 1.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 2.8 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 2.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 0.2 | GO:0097386 | glial cell projection(GO:0097386) |
0.2 | 0.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 1.5 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.7 | GO:0097361 | CIA complex(GO:0097361) |
0.1 | 4.5 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.4 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 6.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 8.4 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 1.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 5.8 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 1.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 1.0 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 6.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 5.7 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 1.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 7.0 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 2.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 2.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.6 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 22.8 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 1.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.9 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 5.4 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 27.9 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 2.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 1.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.4 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 1.9 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 27.2 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.1 | 5.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.7 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 6.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 4.1 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.6 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 1.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 2.2 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 1.0 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.5 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.3 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 1.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 2.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.2 | GO:0034706 | voltage-gated sodium channel complex(GO:0001518) sodium channel complex(GO:0034706) |
0.0 | 0.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.3 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 3.2 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.4 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 15.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.9 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.3 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.3 | GO:0012506 | vesicle membrane(GO:0012506) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.1 | 64.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
11.3 | 78.9 | GO:0099609 | microtubule lateral binding(GO:0099609) |
9.6 | 38.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
7.0 | 27.8 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) phospholipase A2 inhibitor activity(GO:0019834) |
6.8 | 47.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
5.5 | 21.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
5.2 | 20.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
4.7 | 14.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
4.7 | 28.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
4.5 | 31.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
4.4 | 13.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
4.2 | 16.8 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
3.9 | 19.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
3.9 | 15.5 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
3.7 | 11.1 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
3.4 | 3.4 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
3.2 | 16.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
3.2 | 9.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
3.2 | 19.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
3.2 | 15.8 | GO:0005534 | galactose binding(GO:0005534) |
3.2 | 12.6 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
3.1 | 15.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
3.1 | 18.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
3.0 | 9.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
3.0 | 12.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
3.0 | 9.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
3.0 | 9.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
2.9 | 17.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
2.9 | 14.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
2.8 | 14.2 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
2.7 | 32.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
2.7 | 8.0 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
2.7 | 37.4 | GO:0031005 | filamin binding(GO:0031005) |
2.6 | 44.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
2.6 | 7.8 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
2.6 | 7.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
2.5 | 7.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.5 | 7.4 | GO:0051379 | epinephrine binding(GO:0051379) |
2.5 | 32.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
2.4 | 9.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
2.4 | 21.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
2.4 | 4.7 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
2.3 | 7.0 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
2.3 | 25.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
2.2 | 4.5 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
2.2 | 26.4 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
2.2 | 8.8 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
2.2 | 19.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
2.2 | 8.7 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
2.2 | 12.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
2.1 | 14.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
2.1 | 12.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
2.1 | 39.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
2.1 | 10.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
2.1 | 14.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
2.0 | 24.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
2.0 | 8.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
2.0 | 11.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
2.0 | 21.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
2.0 | 5.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
2.0 | 5.9 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.9 | 28.9 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
1.9 | 9.6 | GO:0070330 | aromatase activity(GO:0070330) |
1.9 | 13.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.9 | 5.7 | GO:0016748 | succinyltransferase activity(GO:0016748) |
1.9 | 11.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
1.8 | 14.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.8 | 5.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.8 | 1.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
1.7 | 30.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.7 | 16.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.7 | 13.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.7 | 10.0 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
1.7 | 5.0 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
1.6 | 26.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.6 | 26.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.6 | 8.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.6 | 25.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.6 | 4.8 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
1.6 | 26.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.5 | 15.4 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
1.5 | 4.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
1.5 | 15.2 | GO:0016151 | nickel cation binding(GO:0016151) |
1.5 | 6.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.5 | 15.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
1.5 | 18.0 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.5 | 8.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
1.4 | 19.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.4 | 9.7 | GO:0015288 | porin activity(GO:0015288) |
1.4 | 8.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.3 | 4.0 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
1.3 | 5.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.3 | 21.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.3 | 8.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.3 | 6.3 | GO:0097643 | amylin receptor activity(GO:0097643) |
1.3 | 5.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.2 | 1.2 | GO:0022884 | protein transmembrane transporter activity(GO:0008320) macromolecule transmembrane transporter activity(GO:0022884) |
1.2 | 13.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.2 | 3.7 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
1.2 | 3.6 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
1.2 | 13.0 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
1.2 | 4.7 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.2 | 4.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
1.2 | 3.5 | GO:0001729 | ceramide kinase activity(GO:0001729) |
1.1 | 13.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
1.1 | 3.4 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
1.1 | 10.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.1 | 10.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.1 | 20.5 | GO:0030506 | ankyrin binding(GO:0030506) |
1.1 | 5.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.1 | 21.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
1.1 | 4.2 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
1.1 | 4.2 | GO:0070012 | oligopeptidase activity(GO:0070012) |
1.1 | 3.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
1.0 | 13.6 | GO:0030955 | potassium ion binding(GO:0030955) |
1.0 | 5.2 | GO:0051425 | PTB domain binding(GO:0051425) |
1.0 | 11.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
1.0 | 4.0 | GO:0048495 | Roundabout binding(GO:0048495) |
1.0 | 7.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.0 | 13.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.0 | 9.9 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
1.0 | 5.9 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
1.0 | 8.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.9 | 4.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.9 | 7.5 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.9 | 3.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.9 | 20.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.9 | 7.2 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.9 | 5.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.9 | 3.6 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.9 | 4.5 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.9 | 4.5 | GO:0044020 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.9 | 4.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.9 | 7.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.9 | 2.7 | GO:0031896 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) V2 vasopressin receptor binding(GO:0031896) |
0.9 | 3.5 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.9 | 41.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.9 | 6.8 | GO:0034711 | inhibin binding(GO:0034711) |
0.8 | 5.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.8 | 1.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.8 | 3.3 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.8 | 40.4 | GO:0005267 | potassium channel activity(GO:0005267) |
0.8 | 4.0 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.8 | 3.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.8 | 2.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.8 | 4.8 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.8 | 3.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.8 | 11.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.8 | 21.8 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.8 | 4.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.8 | 3.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.8 | 16.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.8 | 53.3 | GO:0030276 | clathrin binding(GO:0030276) |
0.8 | 3.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.7 | 4.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.7 | 3.7 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.7 | 14.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.7 | 21.5 | GO:0030552 | cAMP binding(GO:0030552) |
0.7 | 7.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.7 | 33.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.7 | 2.1 | GO:0015085 | calcium-transporting ATPase activity(GO:0005388) calcium ion transmembrane transporter activity(GO:0015085) |
0.7 | 2.1 | GO:0048185 | activin binding(GO:0048185) |
0.7 | 2.8 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.7 | 6.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.7 | 2.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.7 | 4.0 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.7 | 2.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.7 | 2.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.7 | 2.0 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.6 | 2.5 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.6 | 17.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.6 | 2.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.6 | 2.4 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.6 | 2.4 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.6 | 20.6 | GO:0005112 | Notch binding(GO:0005112) |
0.6 | 12.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.6 | 31.7 | GO:0005262 | calcium channel activity(GO:0005262) |
0.6 | 2.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.6 | 2.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.6 | 1.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 30.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.6 | 4.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.6 | 18.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.6 | 42.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.6 | 11.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.5 | 26.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.5 | 3.2 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.5 | 20.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.5 | 1.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.5 | 1.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.5 | 3.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.5 | 2.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.5 | 9.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.5 | 2.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.5 | 2.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.5 | 4.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.5 | 2.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.5 | 2.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.5 | 7.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.5 | 2.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.5 | 14.5 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.5 | 4.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.5 | 7.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.5 | 4.0 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.5 | 2.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.5 | 4.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.5 | 1.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.5 | 5.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.5 | 3.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 3.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.5 | 0.9 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.5 | 5.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.5 | 2.8 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
0.5 | 4.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.5 | 2.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 2.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 6.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 1.3 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.4 | 1.8 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.4 | 43.9 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.4 | 3.5 | GO:0070290 | phospholipase D activity(GO:0004630) N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 6.0 | GO:0005537 | mannose binding(GO:0005537) |
0.4 | 6.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.4 | 4.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 7.6 | GO:0016247 | channel regulator activity(GO:0016247) |
0.4 | 2.8 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.4 | 5.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 19.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.4 | 8.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.4 | 4.9 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.4 | 1.9 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.4 | 1.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.4 | 4.4 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.4 | 1.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.4 | 0.7 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.4 | 5.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 15.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.4 | 1.4 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 0.7 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.4 | 3.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.4 | 1.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
0.4 | 1.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.3 | 1.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.3 | 1.0 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
0.3 | 1.0 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.3 | 20.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 1.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 2.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.3 | 11.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.3 | 3.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 1.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 4.8 | GO:0015149 | glucose transmembrane transporter activity(GO:0005355) hexose transmembrane transporter activity(GO:0015149) |
0.3 | 1.0 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 2.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.3 | 5.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 4.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 1.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 3.7 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 8.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.3 | 3.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.3 | 1.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 1.5 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 4.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 7.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 2.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 4.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 2.9 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.3 | 8.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.3 | 2.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 2.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 2.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 2.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.3 | 2.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 0.8 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.3 | 1.1 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.3 | 15.8 | GO:0005179 | hormone activity(GO:0005179) |
0.3 | 0.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 2.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 2.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.3 | 1.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.3 | 1.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.3 | 16.3 | GO:0044325 | ion channel binding(GO:0044325) |
0.3 | 72.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.3 | 9.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.3 | 1.9 | GO:0015266 | protein channel activity(GO:0015266) |
0.3 | 2.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 1.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 3.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 1.5 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.2 | 10.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 2.2 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 1.2 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.2 | 2.6 | GO:0098505 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 46.7 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 0.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 0.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 0.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 2.4 | GO:0042287 | MHC protein binding(GO:0042287) |
0.2 | 1.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 3.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 4.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 1.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 0.6 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.2 | 3.6 | GO:0051117 | ATPase binding(GO:0051117) |
0.2 | 3.0 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 5.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 1.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 1.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 0.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 2.9 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.2 | 2.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 1.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 20.0 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 1.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 1.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 6.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 1.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 8.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.2 | 0.5 | GO:0032564 | dATP binding(GO:0032564) |
0.2 | 4.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 2.0 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.2 | 1.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 5.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 3.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 2.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 0.5 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.2 | 9.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 0.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 0.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 1.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.9 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 5.9 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 2.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 1.8 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.8 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 2.2 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 3.7 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 1.3 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.1 | 2.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.8 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.9 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 3.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.2 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.1 | 0.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 1.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 1.9 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 0.8 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 1.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 2.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 3.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.3 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 6.4 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 2.9 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 2.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.1 | 0.8 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.5 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 4.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 28.3 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 3.8 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 1.5 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 1.3 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 2.1 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 1.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 1.0 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.2 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.1 | 1.4 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.4 | GO:0036310 | annealing helicase activity(GO:0036310) annealing activity(GO:0097617) |
0.0 | 0.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 1.7 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 1.2 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.6 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 1.1 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.0 | 0.1 | GO:0070736 | protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) |
0.0 | 0.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.2 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 87.3 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
3.3 | 10.0 | PID_FAS_PATHWAY | FAS (CD95) signaling pathway |
2.4 | 41.4 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
1.8 | 10.8 | SA_TRKA_RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
1.7 | 29.0 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
1.5 | 76.9 | PID_SYNDECAN_1_PATHWAY | Syndecan-1-mediated signaling events |
1.3 | 47.2 | PID_ARF6_PATHWAY | Arf6 signaling events |
1.3 | 14.4 | PID_THROMBIN_PAR4_PATHWAY | PAR4-mediated thrombin signaling events |
1.2 | 12.0 | PID_TRKR_PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.9 | 5.6 | PID_CXCR4_PATHWAY | CXCR4-mediated signaling events |
0.9 | 6.3 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
0.9 | 42.1 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.9 | 3.5 | PID_PTP1B_PATHWAY | Signaling events mediated by PTP1B |
0.9 | 12.0 | PID_ECADHERIN_NASCENT_AJ_PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.8 | 32.6 | SIG_BCR_SIGNALING_PATHWAY | Members of the BCR signaling pathway |
0.8 | 5.3 | PID_AVB3_OPN_PATHWAY | Osteopontin-mediated events |
0.8 | 12.8 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
0.8 | 45.1 | PID_FAK_PATHWAY | Signaling events mediated by focal adhesion kinase |
0.7 | 54.6 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
0.6 | 4.5 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
0.6 | 5.6 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
0.6 | 6.3 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
0.6 | 3.7 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
0.6 | 8.5 | PID_IL8_CXCR1_PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 16.1 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
0.5 | 24.6 | PID_INSULIN_PATHWAY | Insulin Pathway |
0.5 | 14.8 | ST_MYOCYTE_AD_PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.5 | 3.6 | ST_INTERFERON_GAMMA_PATHWAY | Interferon gamma pathway. |
0.5 | 12.6 | PID_REELIN_PATHWAY | Reelin signaling pathway |
0.5 | 19.7 | PID_SHP2_PATHWAY | SHP2 signaling |
0.5 | 5.8 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 13.4 | PID_BCR_5PATHWAY | BCR signaling pathway |
0.4 | 11.9 | PID_AVB3_INTEGRIN_PATHWAY | Integrins in angiogenesis |
0.4 | 9.0 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling |
0.4 | 10.8 | PID_ALK1_PATHWAY | ALK1 signaling events |
0.3 | 48.1 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 5.6 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 1.2 | ST_GAQ_PATHWAY | G alpha q Pathway |
0.3 | 5.5 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
0.3 | 6.0 | PID_EPHB_FWD_PATHWAY | EPHB forward signaling |
0.3 | 1.2 | PID_IL12_2PATHWAY | IL12-mediated signaling events |
0.3 | 9.2 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
0.3 | 2.5 | PID_IL8_CXCR2_PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 9.0 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
0.2 | 5.0 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 1.9 | PID_IL2_PI3K_PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 1.1 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 3.2 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
0.2 | 0.8 | ST_GA13_PATHWAY | G alpha 13 Pathway |
0.2 | 3.3 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
0.2 | 2.5 | PID_LYSOPHOSPHOLIPID_PATHWAY | LPA receptor mediated events |
0.2 | 8.6 | PID_P73PATHWAY | p73 transcription factor network |
0.2 | 2.1 | PID_EPO_PATHWAY | EPO signaling pathway |
0.2 | 2.9 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 3.0 | PID_ATF2_PATHWAY | ATF-2 transcription factor network |
0.2 | 3.8 | PID_RB_1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 10.4 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
0.1 | 1.3 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.0 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 5.1 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
0.1 | 1.7 | PID_NFAT_TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 19.1 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
0.1 | 12.9 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.9 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.6 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.6 | SIG_CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.9 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.9 | PID_PI3KCI_PATHWAY | Class I PI3K signaling events |
0.1 | 0.6 | PID_EPHRINB_REV_PATHWAY | Ephrin B reverse signaling |
0.1 | 2.0 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.7 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
0.1 | 0.9 | PID_IL2_STAT5_PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 2.0 | PID_BMP_PATHWAY | BMP receptor signaling |
0.1 | 2.0 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.7 | PID_TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.6 | PID_ARF_3PATHWAY | Arf1 pathway |
0.0 | 0.7 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
0.0 | 1.2 | PID_P53_REGULATION_PATHWAY | p53 pathway |
0.0 | 0.4 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.1 | PID_IL1_PATHWAY | IL1-mediated signaling events |
0.0 | 0.5 | PID_CDC42_PATHWAY | CDC42 signaling events |
0.0 | 0.1 | PID_ENDOTHELIN_PATHWAY | Endothelins |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 33.1 | REACTOME_ENDOGENOUS_STEROLS | Genes involved in Endogenous sterols |
3.9 | 90.5 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
3.8 | 18.9 | REACTOME_OLFACTORY_SIGNALING_PATHWAY | Genes involved in Olfactory Signaling Pathway |
3.0 | 9.1 | REACTOME_SEROTONIN_RECEPTORS | Genes involved in Serotonin receptors |
2.7 | 18.6 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
2.5 | 25.1 | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
2.5 | 24.8 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
2.1 | 57.5 | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | Genes involved in DCC mediated attractive signaling |
1.9 | 18.8 | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | Genes involved in Adenylate cyclase activating pathway |
1.8 | 18.2 | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.8 | 24.8 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.7 | 6.8 | REACTOME_GLYCOPROTEIN_HORMONES | Genes involved in Glycoprotein hormones |
1.7 | 11.8 | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
1.6 | 66.9 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
1.5 | 30.4 | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.5 | 19.2 | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | Genes involved in PKA-mediated phosphorylation of CREB |
1.4 | 21.7 | REACTOME_RAF_MAP_KINASE_CASCADE | Genes involved in RAF/MAP kinase cascade |
1.4 | 14.4 | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.4 | 22.8 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.3 | 26.9 | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | Genes involved in Inwardly rectifying K+ channels |
1.3 | 29.5 | REACTOME_INSULIN_RECEPTOR_RECYCLING | Genes involved in Insulin receptor recycling |
1.3 | 1.3 | REACTOME_IL_7_SIGNALING | Genes involved in Interleukin-7 signaling |
1.2 | 14.7 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
1.2 | 39.1 | REACTOME_G_PROTEIN_ACTIVATION | Genes involved in G-protein activation |
1.2 | 29.1 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
1.1 | 29.0 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.1 | 28.8 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.1 | 34.1 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.1 | 3.2 | REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
1.0 | 24.6 | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
1.0 | 37.5 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
0.9 | 12.0 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.9 | 31.8 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.9 | 9.1 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
0.9 | 3.6 | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | Genes involved in Downstream signal transduction |
0.9 | 16.0 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.8 | 15.3 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.8 | 5.9 | REACTOME_SIGNALING_BY_NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.8 | 51.0 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
0.8 | 19.5 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.8 | 6.4 | REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.8 | 24.0 | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.8 | 20.5 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
0.8 | 8.6 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
0.8 | 64.1 | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | Genes involved in MHC class II antigen presentation |
0.8 | 6.1 | REACTOME_SHC_RELATED_EVENTS | Genes involved in SHC-related events |
0.8 | 10.5 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
0.7 | 15.7 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.7 | 2.2 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.7 | 8.8 | REACTOME_ACTIVATION_OF_RAC | Genes involved in Activation of Rac |
0.7 | 12.8 | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.7 | 11.3 | REACTOME_GABA_RECEPTOR_ACTIVATION | Genes involved in GABA receptor activation |
0.7 | 23.3 | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.7 | 8.1 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
0.7 | 11.5 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
0.7 | 17.4 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
0.7 | 4.6 | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.6 | 5.7 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.6 | 12.0 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.6 | 4.4 | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.6 | 3.1 | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.6 | 10.4 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.6 | 95.0 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
0.6 | 8.3 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
0.5 | 3.3 | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.5 | 10.3 | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.5 | 11.4 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.5 | 3.9 | REACTOME_PLATELET_SENSITIZATION_BY_LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 9.6 | REACTOME_ACTIVATION_OF_GENES_BY_ATF4 | Genes involved in Activation of Genes by ATF4 |
0.5 | 12.3 | REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.4 | 4.4 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.4 | 4.8 | REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 4.7 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
0.4 | 4.5 | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.4 | 6.1 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.4 | 6.6 | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.4 | 7.9 | REACTOME_IL_2_SIGNALING | Genes involved in Interleukin-2 signaling |
0.4 | 5.6 | REACTOME_SYNTHESIS_OF_PC | Genes involved in Synthesis of PC |
0.4 | 2.6 | REACTOME_PYRIMIDINE_CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 5.5 | REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 6.2 | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.4 | 2.9 | REACTOME_PD1_SIGNALING | Genes involved in PD-1 signaling |
0.4 | 1.4 | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.3 | 5.2 | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 12.2 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 2.7 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 4.3 | REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 5.2 | REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.3 | 7.2 | REACTOME_PYRUVATE_METABOLISM | Genes involved in Pyruvate metabolism |
0.3 | 3.1 | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.3 | 10.0 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 3.4 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 2.0 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 1.6 | REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.3 | 5.8 | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 14.1 | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 2.5 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 7.0 | REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.2 | 17.0 | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 6.3 | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 8.6 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 2.4 | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 10.1 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 1.9 | REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 1.3 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 4.8 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
0.2 | 4.1 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 1.8 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 2.0 | REACTOME_HDL_MEDIATED_LIPID_TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 8.2 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 2.6 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 2.3 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 2.4 | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 4.8 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 0.8 | REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.2 | 3.9 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 1.8 | REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 3.0 | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.8 | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.7 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 6.6 | REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 3.5 | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 1.1 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 4.2 | REACTOME_PI_METABOLISM | Genes involved in PI Metabolism |
0.1 | 6.5 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 2.2 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 8.3 | REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.2 | REACTOME_MTORC1_MEDIATED_SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 1.0 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 1.6 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.9 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.7 | REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 2.6 | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 1.9 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 4.4 | REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.6 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 2.9 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.9 | REACTOME_RNA_POL_III_CHAIN_ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 0.8 | REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.0 | 0.4 | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.7 | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.1 | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.9 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 1.5 | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.5 | REACTOME_INTERFERON_GAMMA_SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.4 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.1 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 1.6 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.1 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |